COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance

J Cardiovasc Aging. 2022:2:1. doi: 10.20517/jca.2021.20. Epub 2022 Jan 1.

Abstract

Severe systemic inflammation in COVID-19 patients can lead to dysfunction of multiple organs, including the heart. Using an ex vivo cardiac organoid system, Mills et al discovered that inhibitors of the chromatin reader protein, bromodomain-containing protein 4, protect cardiomyocytes from COVID-associated "cytokine storm". We briefly review these important findings and highlight the translational significance of the work.

Keywords: COVID-19; SARS-CoV-2; bromodomain-containing protein 4; cytokine storm; diastolic dysfunction.